EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

BMJ Oncology

ISSN 2752-7948 · BMJ

Latest articles

  1. Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study

    Tawasapon Thambamroong, Ratchadakorn Meesart, Naiyarat Prasongsook, Nuttapong Ngamphaiboon, Charuwan Akewanlop, Suebpong Tanasanvimon, Jarearnjit Phavirunsiri, Nussara Pakvisal, Krittiya Korphaisarn, Chirawadee Sathitruangsak, Teerada Siripoon, Pronwasun Simseekeaw, Chanchai Charonpongsuntorn, Kosin Wirasorn, Gorawich Kerkarchachai, Panuch Eiamprapaporn, Thatthan Suksombooncharoen, Sunatee Sa-nguansai, Alan Patiluntakankul, Ekaphop Sirachainan

    Published: 2026-07DOI: 10.1136/bmjonc-2026-001085

  2. VIP: validation of Italian patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE), a FICOG prospective multicentre study – results of the colorectal cancer (CRC) cohort

    Piera Gargiulo, Francesca Bergamo, Laura Arenare, Claudia Cardone, Silvia Della Torre, Elena Orlandi, Filippo Giovanardi, Camillo Porta, Sara Lonardi, Alfonso De Stefano, Roberto Bollina, Margherita Ratti, Maria Chiara Banzi, Eleonora Bergo, Antonio Avallone, Vittorina Zagonel, Pasquale Stefanelli, Maria Lucia Iacovino, Maria Carmela Piccirillo, Elisabetta Iannelli, Giuseppe Maglietta, Caterina Caminiti, Carmine Pinto, Evaristo Maiello, Francesco Perrone

    Published: 2026-07DOI: 10.1136/bmjonc-2026-001227

  3. First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours

    Carlos Gomez-Roca, Stéphane Champiat, Francois-Xavier Danlos, Eduardo Castañón Álvarez, Philippe Alexandre Cassier, Elena Dupuy, David Jegou, Marie Primard, Aurélie Pétain, Mathilde Saccareau, Geneviève Gueguen-Dorbes, Claire Fabre, Aurélien Marabelle, Ignacio Melero

    Published: 2026-01DOI: 10.1136/bmjonc-2025-000854

  4. BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials

    J Randolph Hecht, Julian R Molina, Kirstin Liechty, Theodore H Welling, Patrick M Grierson, Sandip P Patel, Kedar Kirtane, M Pia Morelli, Frederick L Locke, David G Maloney, Salman R Punekar, Sarah Nikiforow, Yi Lin, Matthew Ulrickson, Jennifer M Specht, Ariane Lozac’hmeur, Chelsea K Osterman, Ryan J Garde, Gena A Rangel, Eric W Ng, John S Welch, Jessica C Tebbets, William Y Go, Diane M Simeone

    Published: 2026-01DOI: 10.1136/bmjonc-2025-001033

Volumes

2026 · 612025 · 732024 · 762023 · 382022 · 1

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.